You are here

Pfizer Oncology Press Kit

Block before Body

Body

PLEASE NOTE: All assets on this page are intended for use by media professionals.

Explore Pfizer’s Commitment to Advancing Oncology

Pfizer Oncology is committed to the discovery, investigation and development of innovative treatment options to improve the outlook for patients across a wide range of cancers. For the latest information on our growing pipeline, product portfolio and collaborations with the broader cancer community, visit this page periodically for leadership perspectives, fact sheets, videos and other media resources.
 
We also encourage you to visit our other online resources for additional information on Pfizer Oncology:
 
 

Blocks after Body

Hear from Pfizer Leadership

pricing_albert_bourla.png The Economics of Optimism: Recognizing the Value of Oncology Innovation » Albert Bourla

Group President, Pfizer Global Innovative Pharma, Global Vaccines, Oncology and Consumer Healthcare

collaboration_liz_barrett.png The Science of Optimism, The Wisdom of Collaboration » Liz Barrett

President and General Manager, Pfizer Oncology

combination_trials_mace_rothenberg.png Why the One-Drug, One-Disease Approach Isn’t Enough:
The New Age of Cancer
Therapy »
Mace Rothenberg, MD

Chief Development Officer,
Oncology,
Pfizer Global Product Development

confirmatory_trials_maria_koehler.png The Patient-Centered Approach to Drug Development » Maria Koehler, MD, PhD

Vice President of Strategy, Innovation and Collaborations for Pfizer Oncology

 

Pfizer Immuno-oncology Video

Recent immunotherapy advances represent new hope for patients with cancer. At Pfizer, we’re primed to go further – and take the next big leap in immuno-oncology.